-
Cost-Effectiveness of Proton Beam Therapy in the Treatment of Pediatric Medulloblastoma in France
Sep 9, 2025, 16:22 PM -
Identifying Risk Profiles for Early Treatment Discontinuation in Geographic Atrophy Using Machine Learning and SHAP Clustering
Sep 9, 2025, 16:22 PM -
Comparative Analysis of Economic Evaluation Frameworks for AI-Based Digital Health Technologies Across Four HTA Systems
Sep 9, 2025, 16:22 PM -
Paving the Path to Success for Joint Clinical Assessments: One Asset at a Time
Sep 9, 2025, 16:22 PM -
Evaluating the Role of Patient-Reported Outcomes in Phase 4 Clinical Trials: Trends, Applications, and Implications for Postmarketing Surveillance
Sep 9, 2025, 16:22 PM -
Higher Mortality for Generalized Pustular Psoriasis Compared With Plaque Psoriasis Highlights the Need for Improved Treatments: Insights From a Meta-Analysis
Sep 9, 2025, 16:22 PM -
Differential HTA Recommendations for Continuous Glucose Monitors (CGMs): A Global Comparative Review of HTA Focus, Challenges, and Solutions
Sep 9, 2025, 16:22 PM -
Budget Impact Analysis of Introducing the Elecsys® PRO-C3 Assay as Part of the ADAPT Algorithm for Assessing the Severity of Hepatic Fibrosis in Patients With Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD) in the UK
Sep 9, 2025, 16:22 PM -
Does the Joint Clinical Assessment (JCA) Enable Health Equity Across Europe? A Review of HTA Practices in the EU
Sep 9, 2025, 16:22 PM -
Advancing INN-Based Prescribing in Saudi Arabia’s Private Sector: Implications for Biologics and Biosimilars Utilization Under CHI Oversight
Sep 9, 2025, 16:22 PM -
Impact of Shared Treatment Decision Making Between Physicians and Patients on Treatment Satisfaction in Hypertension
Sep 9, 2025, 16:22 PM -
A Conceptual Framework for Enhancing the Clinical Utility of a Generic Veterinary Health-Related Quality of Life (HRQoL) Tool Vetmetrica™ Through the Addition of a Disease-Specific Module
Sep 9, 2025, 16:22 PM -
Impact of Pharmacotherapy Adherence on the Reduction of Major Adverse Cardiovascular Events (MACE) Among Atherosclerotic Cardiovascular Disease (ASCVD) Patients
Sep 9, 2025, 16:22 PM -
Reimbursement Trends for Advanced Therapeutic Medicinal Products (ATMPs) in Europe
Sep 9, 2025, 16:22 PM -
Socioeconomic Disparities in Access to Treatment for Major Depressive Disorder: The Role of Accumulator and Maximizer Insurance Plans
Sep 9, 2025, 16:22 PM -
Positioning of the Eluvia™, Drug-Eluting Stent in the Treatment of Peripheral Artery Disease (PAD) in Türkiye: Insights From a Specialist Panel Survey and Focus Group Study
Sep 9, 2025, 16:22 PM -
UDCA Treatment Response in Primary Biliary Cholangitis in the United States
Sep 9, 2025, 16:22 PM -
Quantifying the Economic Burden of Undiagnosed Sleep Apnea in India’s Productive Population: A Health Economic Modeling Approach
Sep 9, 2025, 16:22 PM -
Respiratory Syncytial Virus (RSV) Knowledge and Perceived RSV Risk Groups Amongst GP/PCPs and Specialists in APAC: A Cross-Sectional Knowledge Attitude and Practices Survey (RESVIKAP)
Sep 9, 2025, 16:22 PM -
Budget Impact Analysis of GLP-1 Receptor Agonists for Type 2 Diabetes Management in India
Sep 9, 2025, 16:22 PM
